The impact of mHealth interventions on medication adherence in breast cancer: a systematic review of randomized controlled trials.

IF 2.6 Q1 HEALTH POLICY & SERVICES
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-02-27 eCollection Date: 2026-01-01 DOI:10.1080/20523211.2026.2633827
Rabia Hussain, Bayan F Ababneh, Zaheer-Ud-Din Babar
{"title":"The impact of mHealth interventions on medication adherence in breast cancer: a systematic review of randomized controlled trials.","authors":"Rabia Hussain, Bayan F Ababneh, Zaheer-Ud-Din Babar","doi":"10.1080/20523211.2026.2633827","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Non-adherence to medication can reduce therapeutic effectiveness in breast cancer patients, thereby increasing the risk of disease progression or recurrence. This study aimed to systematically review the existing scientific literature on the impact of mHealth interventions on medication adherence among breast cancer patients.</p><p><strong>Methods: </strong>This systematic review was conducted following PRISMA guidelines and focused on randomised clinical trials published in English. The review evaluated the effectiveness of mHealth interventions in improving medication adherence in breast cancer patients from their inception through June 2025. The databases searched included PubMed, Medline, Cochrane, and Scopus. Study selection, data extraction, and quality assessment were performed by two independent reviewers using Cochrane Risk-of-Bias version 2. The protocol was registered in the INPLASY database (INPLASY2024100061).</p><p><strong>Results: </strong>The review included six randomised controlled trials that met the inclusion criteria. Various mHealth interventions were utilised to improve medication adherence among breast cancer patients. Examples included a smart pill bottle connected to the Pillsy mobile application, SMS reminders, text messaging, phone call reminders, and mobile games. Notably, most mHealth interventions were associated with significant improvements in medication adherence compared to traditional healthcare approaches; however, two studies reported no significant adherence benefits from text messaging compared with standard care. Three out of six studies measured adherence using self-administered questionnaires. For quality assessment, all trials demonstrated adequate randomisation techniques, appropriate allocation concealment, and used appropriate analysis to estimate the effect of assignment to intervention.</p><p><strong>Conclusion: </strong>Breast cancer patients who received mHealth interventions such as SMS reminders, phone call reminders, a smart pill bottle connected to the Pillsy application, and mobile games showed better medication adherence. To implement mHealth interventions, it is crucial to understand key factors that may influence outcomes, including the timing and frequency of interventions, the methods of measuring adherence, patients' preferences, and the duration of intervention assessment.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2633827"},"PeriodicalIF":2.6000,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951683/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2026.2633827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Non-adherence to medication can reduce therapeutic effectiveness in breast cancer patients, thereby increasing the risk of disease progression or recurrence. This study aimed to systematically review the existing scientific literature on the impact of mHealth interventions on medication adherence among breast cancer patients.

Methods: This systematic review was conducted following PRISMA guidelines and focused on randomised clinical trials published in English. The review evaluated the effectiveness of mHealth interventions in improving medication adherence in breast cancer patients from their inception through June 2025. The databases searched included PubMed, Medline, Cochrane, and Scopus. Study selection, data extraction, and quality assessment were performed by two independent reviewers using Cochrane Risk-of-Bias version 2. The protocol was registered in the INPLASY database (INPLASY2024100061).

Results: The review included six randomised controlled trials that met the inclusion criteria. Various mHealth interventions were utilised to improve medication adherence among breast cancer patients. Examples included a smart pill bottle connected to the Pillsy mobile application, SMS reminders, text messaging, phone call reminders, and mobile games. Notably, most mHealth interventions were associated with significant improvements in medication adherence compared to traditional healthcare approaches; however, two studies reported no significant adherence benefits from text messaging compared with standard care. Three out of six studies measured adherence using self-administered questionnaires. For quality assessment, all trials demonstrated adequate randomisation techniques, appropriate allocation concealment, and used appropriate analysis to estimate the effect of assignment to intervention.

Conclusion: Breast cancer patients who received mHealth interventions such as SMS reminders, phone call reminders, a smart pill bottle connected to the Pillsy application, and mobile games showed better medication adherence. To implement mHealth interventions, it is crucial to understand key factors that may influence outcomes, including the timing and frequency of interventions, the methods of measuring adherence, patients' preferences, and the duration of intervention assessment.

移动医疗干预对乳腺癌患者服药依从性的影响:随机对照试验的系统综述。
背景:不坚持服药会降低乳腺癌患者的治疗效果,从而增加疾病进展或复发的风险。本研究旨在系统地回顾现有的关于移动医疗干预对乳腺癌患者药物依从性影响的科学文献。方法:本系统综述遵循PRISMA指南进行,重点关注以英文发表的随机临床试验。该综述评估了移动健康干预措施从一开始到2025年6月在改善乳腺癌患者药物依从性方面的有效性。检索的数据库包括PubMed、Medline、Cochrane和Scopus。研究选择、数据提取和质量评估由两名独立审稿人使用Cochrane风险偏倚版本2进行。协议在INPLASY数据库中注册(INPLASY2024100061)。结果:本综述纳入了6项符合纳入标准的随机对照试验。利用各种移动健康干预措施来改善乳腺癌患者的药物依从性。例子包括连接Pillsy移动应用程序的智能药瓶、短信提醒、短信提醒、电话提醒和手机游戏。值得注意的是,与传统医疗方法相比,大多数移动医疗干预措施与药物依从性的显著改善有关;然而,两项研究报告称,与标准治疗相比,短信治疗没有显著的依从性益处。六项研究中有三项使用自我管理的问卷来衡量依从性。在质量评估方面,所有试验均表现出充分的随机化技术,适当的分配隐藏,并使用适当的分析来估计分配干预的效果。结论:乳腺癌患者接受移动健康干预,如短信提醒、电话提醒、连接Pillsy应用程序的智能药瓶和手机游戏,表现出更好的服药依从性。要实施移动医疗干预,了解可能影响结果的关键因素至关重要,包括干预的时间和频率、衡量依从性的方法、患者的偏好以及干预评估的持续时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书